4369.T
Tri Chemical Laboratories Inc. [4369.T] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
4369.T Stock Summary
Top 10 Correlated ETFs
4369.T
Top 10 Correlated Stocks
4369.T
In the News
4369.T Financial details
Company Rating
Buy
Market Cap
149.49B
Income
2.47B
Revenue
11.25B
Book val./share
-
Cash/share
-
Dividend
30
Dividend %
0.79%
Employees
242
Optionable
No
Shortable
Yes
Earnings
15 Mar 2024
P/E
53.2
Forward P/E
-
PEG
-10.89
P/S
10.33
P/B
4.55
P/C
-
P/FCF
51.37
Quick Ratio
4.91
Current Ratio
6.95
Debt / Equity
0.07
LT Debt / Equity
0.04
-
-
EPS (TTM)
76.03
EPS next Y
-
EPS next Q
-
EPS this Y
-48.87%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-4.17%
Revenue last 5Y
6.35%
Revenue Q/Q
16.92%
EPS Q/Q
57.48%
-
-
-
-
SMA20
-9.4%
SMA50
20.61%
SMA100
29.76%
Inst Own
-
Inst Trans
-
ROA
7%
ROE
9%
ROC
0.07%
Gross Margin
35%
Oper. Margin
17%
Profit Margin
19%
Payout
42%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
2137.0-5430.0
52W High
-23.94%
52W Low
+93.26%
RSI
37
Rel Volume
1.48
Avg Volume
347.79K
Volume
514.8K
Perf Week
-11.09%
Perf Month
-8.93%
Perf Quarter
25.34%
Perf Half Y
20.76%
-
-
-
-
Beta
1.132
-
-
Volatility
168.46%, 245.49%
Prev Close
-6.35%
Price
4130
Change
-3.05%
4369.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2024-01-31
| Metric | History | 2020-01-31 | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 264.58 | 313.69 | 357.07 | 424.76 | 346.07 | |
| Net income per share | 94.08 | 108.08 | 126.33 | 148.7 | 76.03 | |
| Operating cash flow per share | 57.92 | 66.9 | 112.25 | 196.7 | 91.46 | |
| Free cash flow per share | 7.9 | -27.91 | 83.51 | 148.8 | 36.66 | |
| Cash per share | 51.16 | 53.54 | 245.13 | 338.84 | 323.03 | |
| Book value per share | 306.65 | 403.28 | 657.74 | 796.26 | 848.4 | |
| Tangible book value per share | 300.47 | 396.61 | 652.14 | 792.11 | 848.4 | |
| Share holders equity per share | 306.65 | 403.28 | 657.74 | 796.26 | 848.4 | |
| Interest debt per share | 115.83 | 162.59 | 133.13 | 100.73 | 62.78 | |
| Market cap | 83.04B | 133.27B | 99.35B | 75.82B | 119.91B | |
| Enterprise value | 85.01B | 136.62B | 95.6B | 67.92B | 111.82B | |
| P/E ratio | 28.25 | 39.46 | 24.26 | 15.69 | 48.54 | |
| Price to sales ratio | 10.04 | 13.6 | 8.58 | 5.49 | 10.66 | |
| POCF ratio | 45.88 | 63.75 | 27.3 | 11.86 | 40.35 | |
| PFCF ratio | 336.48 | -152.79 | 36.7 | 15.68 | 100.65 | |
| P/B Ratio | 8.67 | 10.58 | 4.66 | 2.93 | 4.35 | |
| PTB ratio | 8.67 | 10.58 | 4.66 | 2.93 | 4.35 | |
| EV to sales | 10.28 | 13.94 | 8.26 | 4.92 | 9.94 | |
| Enterprise value over EBITDA | 19.24 | 26.31 | 15.03 | 9.15 | 34.38 | |
| EV to operating cash flow | 46.97 | 65.35 | 26.27 | 10.63 | 37.62 | |
| EV to free cash flow | 344.46 | -156.63 | 35.32 | 14.05 | 93.85 | |
| Earnings yield | 0.04 | 0.03 | 0.04 | 0.06 | 0.02 | |
| Free cash flow yield | 0 | -0.01 | 0.03 | 0.06 | 0.01 | |
| Debt to equity | 0.37 | 0.4 | 0.2 | 0.13 | 0.07 | |
| Debt to assets | 0.24 | 0.25 | 0.15 | 0.1 | 0.06 | |
| Net debt to EBITDA | 0.45 | 0.64 | -0.59 | -1.06 | -2.49 | |
| Current ratio | 2.02 | 2.31 | 4.15 | 5.15 | 7.44 | |
| Interest coverage | 71.53 | 78.13 | 93.1 | 123.24 | 82.07 | |
| Income quality | 0.48 | 0.48 | 0.69 | 1.03 | 1.2 | |
| Dividend Yield | 0 | 0 | 0.01 | 0.01 | 0.01 | |
| Payout ratio | 0.12 | 0.13 | 0.13 | 0.13 | 0.39 | |
| Sales general and administrative to revenue | 0.02 | 0.02 | 0.02 | 0.09 | 0 | |
| Research and developement to revenue | 0.06 | 0.05 | 0.04 | 0.04 | 0 | |
| Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0 | 0 | |
| Capex to operating cash flow | -0.86 | -1.42 | -0.26 | -0.24 | -0.6 | |
| Capex to revenue | -0.19 | -0.3 | -0.08 | -0.11 | -0.16 | |
| Capex to depreciation | -2.43 | -3.64 | -0.91 | -1.29 | -1.36 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 805.68 | 990.31 | 1.37K | 1.63K | 1.2K | |
| ROIC | 0.13 | 0.11 | 0.09 | 0.09 | 0.05 | |
| Return on tangible assets | 0.2 | 0.17 | 0.15 | 0.15 | 0.08 | |
| Graham Net | -55.13 | -86.46 | 134.08 | 269.88 | 345.9 | |
| Working capital | 3.1B | 4.29B | 10.92B | 15.25B | 16.45B | |
| Tangible asset value | 9.39B | 12.39B | 21.14B | 25.74B | 27.46B | |
| Net current asset value | 584.75M | 318.33M | 7.42B | 12.68B | 14.71B | |
| Invested capital | 0.37 | 0.4 | 0.2 | 0.13 | 0.07 | |
| Average receivables | 2.01B | 2.48B | 2.92B | 3.28B | 3.77B | |
| Average payables | 377.88M | 463.95M | 569.8M | 877.92M | 748.23M | |
| Average inventory | 1.08B | 1.42B | 1.88B | 2.45B | 3.38B | |
| Days sales outstanding | 95.86 | 103.64 | 96.44 | 92.68 | 130.97 | |
| Days payables outstanding | 34.01 | 35.4 | 33.24 | 50.69 | 18.07 | |
| Days of inventory on hand | 103.69 | 108.33 | 116.46 | 121.6 | 205.07 | |
| Receivables turnover | 3.81 | 3.52 | 3.78 | 3.94 | 2.79 | |
| Payables turnover | 10.73 | 10.31 | 10.98 | 7.2 | 20.2 | |
| Inventory turnover | 3.52 | 3.37 | 3.13 | 3 | 1.78 | |
| ROE | 0.31 | 0.27 | 0.19 | 0.19 | 0.09 | |
| Capex per share | -50.02 | -94.81 | -28.74 | -47.89 | -54.79 |
Quarterly Fundamentals Overview
Last date of statement is 2024-01-31 for Q4
| Metric | History | 2023-01-31 | 2023-04-30 | 2023-07-31 | 2023-10-31 | 2024-01-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 112.76 | 99.35 | 73.66 | 79.78 | 0 | |
| Net income per share | 14.08 | 30.54 | 14.18 | 12.16 | 0 | |
| Operating cash flow per share | 27.04 | 80.62 | 31.7 | -10.65 | 0 | |
| Free cash flow per share | 15.54 | 73.17 | 5.17 | -20.39 | 0 | |
| Cash per share | 342.73 | 381.2 | 362.59 | 350.42 | 0 | |
| Book value per share | 796.26 | 794.41 | 814.43 | 828.9 | 0 | |
| Tangible book value per share | 792.11 | 790.64 | 811.05 | 828.9 | 0 | |
| Share holders equity per share | 796.26 | 794.41 | 814.43 | 828.9 | 0 | |
| Interest debt per share | 100.06 | 77.2 | 70.54 | 64.8 | 0 | |
| Market cap | 75.82B | 71.23B | 85.63B | 102.69B | 0 | |
| Enterprise value | 67.92B | 61.35B | 75.67B | 93.4B | -8.1B | |
| P/E ratio | 41.41 | 17.94 | 46.46 | 64.98 | 0 | |
| Price to sales ratio | 20.69 | 22.06 | 35.77 | 39.61 | 0 | |
| POCF ratio | 86.28 | 27.19 | 83.13 | -296.81 | 0 | |
| PFCF ratio | 150.13 | 29.96 | 509.36 | -155 | 0 | |
| P/B Ratio | 2.93 | 2.76 | 3.24 | 3.81 | 0 | |
| PTB ratio | 2.93 | 2.76 | 3.24 | 3.81 | 0 | |
| EV to sales | 18.54 | 19 | 31.61 | 36.03 | -2.67 | |
| Enterprise value over EBITDA | 76.69 | 37.29 | 80.52 | 108.46 | -8.78 | |
| EV to operating cash flow | 77.3 | 23.42 | 73.46 | -269.97 | 24.39 | |
| EV to free cash flow | 134.5 | 25.8 | 450.12 | -140.98 | 11.7 | |
| Earnings yield | 0.01 | 0.01 | 0.01 | 0 | 0 | |
| Free cash flow yield | 0.01 | 0.03 | 0 | -0.01 | 0 | |
| Debt to equity | 0.13 | 0.1 | 0.09 | 0.08 | 0.07 | |
| Debt to assets | 0.1 | 0.08 | 0.07 | 0.07 | 0.06 | |
| Net debt to EBITDA | -8.91 | -6.01 | -10.6 | -10.78 | -8.78 | |
| Current ratio | 5.15 | 6.51 | 6.12 | 6.95 | 7.44 | |
| Interest coverage | 104.67 | 140.59 | 36.85 | 45.5 | 104.86 | |
| Income quality | 1.53 | 2.02 | 1.69 | -0.65 | -0.53 | |
| Dividend Yield | 0 | 0.01 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0.92 | 0.13 | 0 | 0 | |
| Sales general and administrative to revenue | 0.05 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0.04 | 0.04 | 0.07 | 0.07 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -0.43 | -0.09 | -0.84 | 0.91 | 1.08 | |
| Capex to revenue | -0.1 | -0.08 | -0.36 | -0.12 | -0.12 | |
| Capex to depreciation | -1.22 | -0.76 | -2.68 | -0.98 | -1.06 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 502.32 | 738.84 | 509.75 | 476.16 | 0 | |
| ROIC | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | |
| Return on tangible assets | 0.01 | 0.03 | 0.01 | 0.01 | 0.02 | |
| Graham Net | 273.78 | 339.71 | 311.08 | 319.02 | 0 | |
| Working capital | 15.25B | 17.12B | 16.42B | 16.4B | 16.45B | |
| Tangible asset value | 25.74B | 25.69B | 26.36B | 26.82B | 27.46B | |
| Net current asset value | 12.68B | 14.81B | 14.3B | 14.49B | 14.71B | |
| Invested capital | 0.13 | 0.1 | 0.09 | 0.08 | 0.07 | |
| Average receivables | 3.72B | 3.41B | 2.86B | 2.28B | 3.09B | |
| Average payables | 1.07B | 937.36M | 813.27M | 901.43M | 631.7M | |
| Average inventory | 2.76B | 2.94B | 3.42B | 3.88B | 4.05B | |
| Days sales outstanding | 86.08 | 92.46 | 90.39 | 74.61 | 119.81 | |
| Days payables outstanding | 42.76 | 35.65 | 49.77 | 45.53 | 16.81 | |
| Days of inventory on hand | 102.6 | 153.02 | 205.33 | 203.77 | 190.83 | |
| Receivables turnover | 1.05 | 0.97 | 1 | 1.21 | 0.75 | |
| Payables turnover | 2.1 | 2.52 | 1.81 | 1.98 | 5.35 | |
| Inventory turnover | 0.88 | 0.59 | 0.44 | 0.44 | 0.47 | |
| ROE | 0.02 | 0.04 | 0.02 | 0.01 | 0.02 | |
| Capex per share | -11.5 | -7.45 | -26.52 | -9.74 | 0 |
4369.T Frequently Asked Questions
What is Tri Chemical Laboratories Inc. stock symbol ?
Tri Chemical Laboratories Inc. is a JP stock and trading under the symbol 4369.T
What is Tri Chemical Laboratories Inc. stock quote today ?
Tri Chemical Laboratories Inc. stock price is $4130 today.
Is Tri Chemical Laboratories Inc. stock public?
Yes, Tri Chemical Laboratories Inc. is a publicly traded company.
Company Profile
- Volume Average 347.79K
- Market Capitalization 149.49B
- Employee 242
- CEO Mr. Kiyoshi Tazuke
- Headquarters Uenohara,JP
- IPO Date 2007-08-03
-
Website
https://www.trichemical.com 
Tri Chemical Laboratories Inc. provides precursors for semiconductors, optical fibers, solar cells, and compound semiconductors. It also offers catalysts, special reagents, etc. In addition, the company provides containers, such as stainless-steel containers with valves, seamless cylinders for high pressure gas, glass ampoules, polyethylene bottles, glass bottles, and glass vial bottles. Tri Chemical Laboratories Inc. was incorporated in 1978 and is headquartered in Uenohara, Japan.
